The successful use of tacrolimus (FK506) in a pancreas/kidney transplant recipient with recurrent cyclosporine-associated hemolytic uremic syndrome.
Kaufman
D B
DB
Department of Surgery, Northwestern University Medical School, Chicago, Illinois 60611, USA.
Kaplan
B
B
Kanwar
Y S
YS
Abecassis
M
M
Stuart
F P
FP
D000328:Adult; D016572:Cyclosporine / Q000009:adverse effects*; D006084:Graft Rejection / Q000188:drug therapy; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D016035:Pancreas Transplantation / Q000009:adverse effects* / Q000276:immunology; D016559:Tacrolimus / Q000627:therapeutic use*
D016572:Cyclosporine; D016559:Tacrolimus